<?xml version="1.0" encoding="UTF-8"?>
<p>Considering the urgent need to find a treatment for COVID-19, two approaches were nominated: (i) a short term approach with immediate results—administration of approved drugs (originally introduced for other pathologies) with a high safety profile that showed promising in vitro results against SARS-CoV, MERS-CoV, and SARS-CoV-2 combined with convalescent plasma treatment (agents tested in ongoing clinical trials); and (ii) a long term approach—development of novel antiviral agents and vaccines against SARS-CoV-2.</p>
